This report studies Active Pharma Ingredient in Global market, especially in North America, China, Europe, Southeast Asia, Japan, and India, with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.
Active Pharmaceutical Ingredient (API) produces the intended effects in a drug. A drug can contain a single API or have multiple API for the treatment of different symptoms in a particular disease. According to the U.S. Food and Drug Administration, any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal) product and that, when used in the production of a drug, becomes an active ingredient of the drug product.
The increasing prevalence of chronic diseases is expected to boost the growth of the global active pharmaceutical ingredients market over the forecast period. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018. Moreover, high incidence of cardiovascular diseases (CVDs) is also expected to aid in the growth of the market. For instance, according to the American Heart Association’s Heart Disease and Stroke Statistics 2018, around 92.1 million adults in the U.S. are suffering from some form of CVD or the after-effects of stroke.
R&D in API is expected to offer lucrative growth opportunities for players in the global active pharmaceutical ingredients market. For instance, in June 2019, researchers from Bristol-Myers Squibb reported advantages of utilizing population balance modeling of crystallization processes for particle size distribution prediction of an API, in the journal MDPI Processes. Moreover, the development of ionic liquid APIs is also expected to aid in the growth of the market. For instance, in November 2018, researchers from the University of Vigo, Spain, reported the transformation of two solid APIs, indomethacin and mebendazole, into new API- ionic liquids.
However, stringent regulations, higher manufacturing costs, and increased competition are some of the factors that are expected to hinder the growth of the global active pharmaceutical ingredients market. For instance, in November 2019, Teva Pharmaceuticals halted production at its API plant in Italy, owing to a mandate of regulatory authorities to submit new registration requests for products produced at the site.
Major players in the market are focused on investment in R&D of APIs to expand their product portfolio. For instance, in April 2018, STA Pharmaceutical, a subsidiary of WuXi AppTec, signed an investment agreement with the government of Shanghai to build a new R&D center for APIs and intermediates.
Key Takeaways:
- Increasing prevalence of chronic diseases to augment the growth of the global active pharmaceutical ingredients market over the forecast period
- R&D in API is expected to offer lucrative growth opportunities for players in the market
- Major players operating in the global active pharmaceutical ingredients market include Albemarle, Aurobindo Pharma, BASF, Bayer, Biocon, Boehringer Ingelheim GmbH, Cambrex, Cipla, Dr. Reddy's Laboratories, DSM, Haerbin Pharmaceutical Group, Hisun Pharmacy, Huahai Pharmaceutical, Jiangsu Hengrui Medicine, Johnson & Johnson, Johnson Matthey, Lonza Group, Lupin, Mylan, North China Pharmaceutical Group, North East Pharmaceutical, Novartis, Pfizer, Roche, Shandong Lukang Pharmaceutical, Shandong Xinhua Pharmaceutical, STA Pharmaceutical, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Tian Yao, and Zhejiang Medicine
This report focuses on top manufacturers in the global market, with production, price, revenue, and market share for each manufacturer, covering
⤍ Teva
⤍ Novartis
⤍ Pfizer
⤍ Johnson & Johnson
⤍ Mylan
⤍ North China Pharmaceutical Group
⤍ Dr. Reddy's Laboratories
⤍ Roche
⤍ Aurobindo pharma
⤍ Sun Pharmaceutical Industries
⤍ Boehringer Ingelheim GmbH
⤍ Bayer
⤍ BASF
⤍ DSM
⤍ Zhejiang Medicine
⤍ Biocon
⤍ Johnson Matthey
⤍ Hisun Pharmacy
⤍ Cambrex
⤍ Shandong Xinhua Pharmaceutical
⤍ Lonza group
⤍ Huahai Pharmaceutical
⤍ Haerbin Pharmaceutical Group
⤍ Cipla
⤍ Tian Yao
⤍ Lupin
⤍ North East Pharmaceutical
⤍ Albemarle
⤍ Shandong Lukang Pharmaceutical
⤍ Jiangsu Hengrui Medicine
On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into
⤍ Innovative Active Pharmaceutical Ingredients
⤍ Generic Active Pharmaceutical Ingredients
By Application, the market can be split into
⤍ Oncology
⤍ Cardiovascular Disease
⤍ Diabetes
⤍ Central Nervous System and Neurological Disorders
⤍ Endocrinology
⤍ Other Therapeutic Applications
By Regions, this report covers (we can add the regions/countries as you want)
⤍ North America
⤍ China
⤍ Europe
⤍ Southeast Asia
⤍ Japan
⤍ India
[**NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.]
Table of Contents
Global Active Pharma Ingredient Market Professional Survey Report 2019
1 Industry Overview of Active Pharma Ingredient
1.1 Definition and Specifications of Active Pharma Ingredient
1.1.1 Definition of Active Pharma Ingredient
1.1.2 Specifications of Active Pharma Ingredient
1.2 Classification of Active Pharma Ingredient
1.2.1 Innovative Active Pharmaceutical Ingredients
1.2.2 Generic Active Pharmaceutical Ingredients
1.3 Applications of Active Pharma Ingredient
1.3.1 Oncology
1.3.2 Cardiovascular Disease
1.3.3 Diabetes
1.3.4 Central Nervous System and Neurological Disorders
1.3.5 Endocrinology
1.3.6 Other Therapeutic Applications
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Active Pharma Ingredient
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Active Pharma Ingredient
2.3 Manufacturing Process Analysis of Active Pharma Ingredient
2.4 Industry Chain Structure of Active Pharma Ingredient
3 Technical Data and Manufacturing Plants Analysis of Active Pharma Ingredient
3.1 Capacity and Commercial Production Date of Global Active Pharma Ingredient Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Active Pharma Ingredient Major Manufacturers in 2018
3.3 R&D Status and Technology Source of Global Active Pharma Ingredient Major Manufacturers in 2018
3.4 Raw Materials Sources Analysis of Global Active Pharma Ingredient Major Manufacturers in 2018
4 Global Active Pharma Ingredient Overall Market Overview
4.1 2014-2019E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2014-2019E Global Active Pharma Ingredient Capacity and Growth Rate Analysis
4.2.2 2018 Active Pharma Ingredient Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2014-2019E Global Active Pharma Ingredient Sales and Growth Rate Analysis
4.3.2 2018 Active Pharma Ingredient Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2014-2019E Global Active Pharma Ingredient Sales Price
4.4.2 2018 Active Pharma Ingredient Sales Price Analysis (Company Segment)
5 Active Pharma Ingredient Regional Market Analysis
5.1 North America Active Pharma Ingredient Market Analysis
5.1.1 North America Active Pharma Ingredient Market Overview
5.1.2 North America 2014-2019E Active Pharma Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2014-2019E Active Pharma Ingredient Sales Price Analysis
5.1.4 North America 2018 Active Pharma Ingredient Market Share Analysis
5.2 China Active Pharma Ingredient Market Analysis
5.2.1 China Active Pharma Ingredient Market Overview
5.2.2 China 2014-2019E Active Pharma Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2014-2019E Active Pharma Ingredient Sales Price Analysis
5.2.4 China 2018 Active Pharma Ingredient Market Share Analysis
5.3 Europe Active Pharma Ingredient Market Analysis
5.3.1 Europe Active Pharma Ingredient Market Overview
5.3.2 Europe 2014-2019E Active Pharma Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2014-2019E Active Pharma Ingredient Sales Price Analysis
5.3.4 Europe 2018 Active Pharma Ingredient Market Share Analysis
5.4 Southeast Asia Active Pharma Ingredient Market Analysis
5.4.1 Southeast Asia Active Pharma Ingredient Market Overview
5.4.2 Southeast Asia 2014-2019E Active Pharma Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2014-2019E Active Pharma Ingredient Sales Price Analysis
5.4.4 Southeast Asia 2018 Active Pharma Ingredient Market Share Analysis
5.5 Japan Active Pharma Ingredient Market Analysis
5.5.1 Japan Active Pharma Ingredient Market Overview
5.5.2 Japan 2014-2019E Active Pharma Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2014-2019E Active Pharma Ingredient Sales Price Analysis
5.5.4 Japan 2018 Active Pharma Ingredient Market Share Analysis
5.6 India Active Pharma Ingredient Market Analysis
5.6.1 India Active Pharma Ingredient Market Overview
5.6.2 India 2014-2019E Active Pharma Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2014-2019E Active Pharma Ingredient Sales Price Analysis
5.6.4 India 2018 Active Pharma Ingredient Market Share Analysis
6 Global 2014-2019E Active Pharma Ingredient Segment Market Analysis (by Type)
6.1 Global 2014-2019E Active Pharma Ingredient Sales by Type
6.2 Different Types of Active Pharma Ingredient Product Interview Price Analysis
6.3 Different Types of Active Pharma Ingredient Product Driving Factors Analysis
6.3.1 Innovative Active Pharmaceutical Ingredients of Active Pharma Ingredient Growth Driving Factor Analysis
6.3.2 Generic Active Pharmaceutical Ingredients of Active Pharma Ingredient Growth Driving Factor Analysis
7 Global 2014-2019E Active Pharma Ingredient Segment Market Analysis (by Application)
7.1 Global 2014-2019E Active Pharma Ingredient Consumption by Application
7.2 Different Application of Active Pharma Ingredient Product Interview Price Analysis
7.3 Different Application of Active Pharma Ingredient Product Driving Factors Analysis
7.3.1 Oncology of Active Pharma Ingredient Growth Driving Factor Analysis
7.3.2 Cardiovascular Disease of Active Pharma Ingredient Growth Driving Factor Analysis
7.3.3 Diabetes of Active Pharma Ingredient Growth Driving Factor Analysis
7.3.4 Central Nervous System and Neurological Disorders of Active Pharma Ingredient Growth Driving Factor Analysis
7.3.5 Endocrinology of Active Pharma Ingredient Growth Driving Factor Analysis
7.3.6 Other Therapeutic Applications of Active Pharma Ingredient Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Active Pharma Ingredient
8.1 Teva
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Teva 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Teva 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novartis 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.3 Pfizer
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Pfizer 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Pfizer 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.4 Johnson & Johnson
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Johnson & Johnson 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Johnson & Johnson 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Mylan 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.6 North China Pharmaceutical Group
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 North China Pharmaceutical Group 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 North China Pharmaceutical Group 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.7 Dr. Reddy's Laboratories
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Dr. Reddy's Laboratories 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Dr. Reddy's Laboratories 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.8 Roche
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Roche 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Roche 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.9 Aurobindo pharma
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Aurobindo pharma 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Aurobindo pharma 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.10 Sun Pharmaceutical Industries
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Sun Pharmaceutical Industries 2018 Active Pharma Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Sun Pharmaceutical Industries 2018 Active Pharma Ingredient Business Region Distribution Analysis
8.11 Boehringer Ingelheim GmbH
8.12 Bayer
8.13 BASF
8.14 DSM
8.15 Zhejiang Medicine
8.16 Biocon
8.17 Johnson Matthey
8.18 Hisun Pharmacy
8.19 Cambrex
8.20 Shandong Xinhua Pharmaceutical
8.21 Lonza group
8.22 Huahai Pharmaceutical
8.23 Haerbin Pharmaceutical Group
8.24 Cipla
8.25 Tian Yao
8.26 Lupin
8.27 North East Pharmaceutical
8.28 Albemarle
8.29 Shandong Lukang Pharmaceutical
8.30 Jiangsu Hengrui Medicine
9 Development Trend of Analysis of Active Pharma Ingredient Market
9.1 Global Active Pharma Ingredient Market Trend Analysis
9.1.1 Global 2019-2022 Active Pharma Ingredient Market Size (Volume and Value) Forecast
9.1.2 Global 2019-2022 Active Pharma Ingredient Sales Price Forecast
9.2 Active Pharma Ingredient Regional Market Trend
9.2.1 North America 2019-2022 Active Pharma Ingredient Consumption Forecast
9.2.2 China 2019-2022 Active Pharma Ingredient Consumption Forecast
9.2.3 Europe 2019-2022 Active Pharma Ingredient Consumption Forecast
9.2.4 Southeast Asia 2019-2022 Active Pharma Ingredient Consumption Forecast
9.2.5 Japan 2019-2022 Active Pharma Ingredient Consumption Forecast
9.2.6 India 2019-2022 Active Pharma Ingredient Consumption Forecast
9.3 Active Pharma Ingredient Market Trend (Product Type)
9.4 Active Pharma Ingredient Market Trend (Application)
10 Active Pharma Ingredient Marketing Type Analysis
10.1 Active Pharma Ingredient Regional Marketing Type Analysis
10.2 Active Pharma Ingredient International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Active Pharma Ingredient by Region
10.4 Active Pharma Ingredient Supply Chain Analysis
11 Consumers Analysis of Active Pharma Ingredient
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Active Pharma Ingredient Market Professional Survey Report 2019
Methodology
Analyst Introduction
Data Source
Request Discount 
Inquire Before Buy
